Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing
Concerns that well-funded Chinese companies will swoop in to grab new ideas for their own drug development are shaping an industry unaccustomed to such secrecy.
Read the original story ↗